These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 33092631)
1. Diagnostic value of Tsuyoshi H; Tsujikawa T; Yamada S; Okazawa H; Yoshida Y Cancer Imaging; 2020 Oct; 20(1):75. PubMed ID: 33092631 [TBL] [Abstract][Full Text] [Related]
2. Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Takahashi S; Ebina Y; Miyahara Y; Yamada H; Sugimura K Eur J Radiol; 2013 Oct; 82(10):1672-6. PubMed ID: 23727380 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of [ Tsuyoshi H; Tsujikawa T; Yamada S; Okazawa H; Yoshida Y EJNMMI Res; 2020 Oct; 10(1):117. PubMed ID: 33006685 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology. Heusch P; Nensa F; Schaarschmidt B; Sivanesapillai R; Beiderwellen K; Gomez B; Köhler J; Reis H; Ruhlmann V; Buchbender C Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):42-8. PubMed ID: 25112399 [TBL] [Abstract][Full Text] [Related]
5. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Kim HJ; Cho A; Yun M; Kim YT; Kang WJ Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334 [TBL] [Abstract][Full Text] [Related]
6. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Sarabhai T; Schaarschmidt BM; Wetter A; Kirchner J; Aktas B; Forsting M; Ruhlmann V; Herrmann K; Umutlu L; Grueneisen J Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):67-76. PubMed ID: 28840302 [TBL] [Abstract][Full Text] [Related]
11. Whole-body Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514 [TBL] [Abstract][Full Text] [Related]
12. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [TBL] [Abstract][Full Text] [Related]
13. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685 [TBL] [Abstract][Full Text] [Related]
14. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer. Sudo S; Hattori N; Manabe O; Kato F; Mimura R; Magota K; Sugimori H; Hirata K; Sakuragi N; Tamaki N Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022 [TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results. Bruckmann NM; Kirchner J; Morawitz J; Umutlu L; Herrmann K; Bittner AK; Hoffmann O; Mohrmann S; Ingenwerth M; Schaarschmidt BM; Li Y; Stang A; Antoch G; Sawicki LM; Buchbender C PLoS One; 2021; 16(12):e0260804. PubMed ID: 34855886 [TBL] [Abstract][Full Text] [Related]
16. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673 [TBL] [Abstract][Full Text] [Related]
17. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Suzuki R; Miyagi E; Takahashi N; Sukegawa A; Suzuki A; Koike I; Sugiura K; Okamoto N; Inoue T; Hirahara F Int J Gynecol Cancer; 2007; 17(4):890-6. PubMed ID: 17343574 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Accuracy of FEC-PET/CT, FDG-PET/CT, and Diffusion-Weighted MRI in Detection of Nodal Metastases in Surgically Treated Endometrial and Cervical Carcinoma. Rockall AG; Barwick TD; Wilson W; Singh N; Bharwani N; Sohaib A; Nobbenhuis M; Warbey V; Miquel M; Koh DM; De Paepe KN; Martin-Hirsch P; Ghaem-Maghami S; Fotopoulou C; Stringfellow H; Sundar S; Manchanda R; Sahdev A; Hackshaw A; Cook GJ; Clin Cancer Res; 2021 Dec; 27(23):6457-6466. PubMed ID: 34526364 [TBL] [Abstract][Full Text] [Related]
19. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656 [TBL] [Abstract][Full Text] [Related]
20. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]